(Q46675079)

English

Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokines

scientific article published in September 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16128865

Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokines (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16128865

1 reference

based on heuristic

inferred from title

HIV-associated lipodystrophy

1 reference

based on heuristic

inferred from title

Steen B. Pedersen

5

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16128865

6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16128865

2

object named as

Andersen O

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

author name string

He G

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16128865

Haugaard SB

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16128865

Lihn AS

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16128865

Richelsen B

7

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16128865

Richelsen B

8

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16128865

publication date

1 September 2005

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16128865

European Journal of Clinical Investigation

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16128865

35

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16128865

9

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16128865

583-590

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16128865

Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01547.X

21 January 2018

Adverse effects of antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01547.X

21 January 2018

Lipodystrophy syndrome by HAART in HIV-infected patients: manifestation, mechanisms and management

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01547.X

21 January 2018

Insulin resistance in the HIV-lipodystrophy syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01547.X

21 January 2018

Hypofibrinolytic state in HIV-1-infected patients treated with protease inhibitor-containing highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01547.X

21 January 2018

Plasminogen-activator inhibitor type 1 and coronary artery disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01547.X

21 January 2018

Visceral fat accumulation is an important determinant of PAI-1 levels in young, nonobese men and women: modulation by cross-sex hormone administration.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01547.X

21 January 2018

Visceral fat is a determinant of PAI-1 activity in diabetic and non-diabetic overweight and obese women.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01547.X

21 January 2018

PAI-1 produced ex vivo by human adipose tissue is relevant to PAI-1 blood level.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01547.X

21 January 2018

Regulation of plasma PAI-1 concentrations in HAART-associated lipodystrophy during rosiglitazone therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01547.X

21 January 2018

Effects of troglitazone and metformin on glucose and lipid metabolism: alterations of two distinct molecular pathways

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01547.X

21 January 2018

Expression of plasminogen activator inhibitor-1 in human adipose tissue: a role for TNF-alpha?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01547.X

21 January 2018

Tumor necrosis factor alpha is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01547.X

21 January 2018

Divergent roles for p55 and p75 TNF-alpha receptors in the induction of plasminogen activator inhibitor-1.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01547.X

21 January 2018

Studies of adipose tissue metabolism in human immunodeficiency virus-associated lipodystrophy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01547.X

21 January 2018

Association of severe insulin resistance with both loss of limb fat and elevated serum tumor necrosis factor receptor levels in HIV lipodystrophy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01547.X

21 January 2018

Synergistic antiadipogenic effects of HIV type 1 protease inhibitors with tumor necrosis factor alpha: suppression of extracellular insulin action mediated by extracellular matrix-degrading proteases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01547.X

21 January 2018

Stromal cells are the main plasminogen activator inhibitor-1-producing cells in human fat: evidence of differences between visceral and subcutaneous deposits.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01547.X

21 January 2018

Increased expression of TNF-alpha, IL-6, and IL-8 in HALS: implications for reduced adiponectin expression and plasma levels

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01547.X

21 January 2018

Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01547.X

21 January 2018

Stimulation of PAI-1 and adipokines by glucose in human adipose tissue in vitro.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01547.X

21 January 2018

Identifiers

10.1111/J.1365-2362.2005.01547.X

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16128865

release_rpcwx6niwbfafp4jjcanqnqunu

1 reference

https://api.fatcat.wiki/v0/release/rpcwx6niwbfafp4jjcanqnqunu

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16128865

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46675079&oldid=2125826732"